Show simple item record

dc.contributor.authorShah, V
dc.contributor.authorSherborne, AL
dc.contributor.authorJohnson, DC
dc.contributor.authorEllis, S
dc.contributor.authorPrice, A
dc.contributor.authorChowdhury, F
dc.contributor.authorKendall, J
dc.contributor.authorJenner, MW
dc.contributor.authorDrayson, MT
dc.contributor.authorOwen, RG
dc.contributor.authorGregory, WM
dc.contributor.authorMorgan, GJ
dc.contributor.authorDavies, FE
dc.contributor.authorCook, G
dc.contributor.authorCairns, DA
dc.contributor.authorHoulston, RS
dc.contributor.authorJackson, G
dc.contributor.authorKaiser, MF
dc.contributor.authoron behalf of NCRI Haematology Clinical Studies Group,
dc.date.accessioned2020-04-02T11:47:31Z
dc.date.issued2020-03-11
dc.identifier.citationLeukemia, 2020, 34 (11), pp. 3091 - 3096
dc.identifier.issn0887-6924
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3574
dc.identifier.eissn1476-5551
dc.identifier.doi10.1038/s41375-020-0750-z
dc.formatPrint-Electronic
dc.format.extent3091 - 3096
dc.languageeng
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjecton behalf of NCRI Haematology Clinical Studies Group
dc.subjectHumans
dc.subjectMultiple Myeloma
dc.subjectChromosome Aberrations
dc.subjectPrognosis
dc.subjectStem Cell Transplantation
dc.subjectProportional Hazards Models
dc.subjectGene Expression Profiling
dc.subjectTranscriptome
dc.subjectBiomarkers, Tumor
dc.titlePredicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients.
dc.typeJournal Article
dcterms.dateAccepted2020-02-06
rioxxterms.versionofrecord10.1038/s41375-020-0750-z
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfLeukemia
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Myeloma Group
pubs.publication-statusPublished
pubs.volume34
pubs.embargo.termsNot known
icr.researchteamCancer Genomics
icr.researchteamMyeloma Group
dc.contributor.icrauthorHoulston, Richard
dc.contributor.icrauthorKaiser, Martin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0